Previous Article | Next Article ![]()
Journal of Clinical Microbiology, September 2000, p. 3235-3239, Vol. 38, No. 9
Centre for Health and Population Research,
ICDDR,B,1 and Department of Microbiology
and Hepatology, Bangabandhu Sheikh Mujib Medical
University,2 Dhaka, Bangladesh, and
TechLab, Inc., Blacksburg,3 and
Departments of Medicine, Microbiology and Pathology, University
of Virginia, Charlottesville,4 Virginia
Received 21 March 2000/Returned for modification 6 June
2000/Accepted 22 June 2000
A noninvasive diagnostic test for amebic liver abscess is needed,
because amebic and bacterial abscesses appear identical on ultrasound
or computer tomography and because it is rarely possible to identify
Entamoeba histolytica in stool specimens from patients with
amebic liver abscess. Here we report a method of detection in serum of
circulating E. histolytica Gal/GalNAc lectin to diagnose
amebic liver abscess, which was used in patients from Dhaka,
Bangladesh. The TechLab E. histolytica II test (which differentiates the true pathogen E. histolytica from
Entamoeba dispar) detected Gal/GalNAc lectin in the sera of
22 of 23 (96%) amebic liver abscess patients tested prior to treatment
with the antiamebic drug metronidazole and 0 of 70 (0%) controls.
After 1 week of treatment with metronidazole, 9 of 11 (82%) patients became serum lectin antigen negative. The sensitivity of the E. histolytica II antigen detection test for intestinal infection was also evaluated. Antigen detection identified E. histolytica infection in 50 samples from 1,164 asymptomatic
preschool children aged 2 to 5 years, including 16 of 16 (100%)
culture-positive specimens. PCR analysis of stool specimens was used to
confirm that most antigen-positive but culture-negative specimens were true-positive: PCR identified parasite DNA in 27 of 34 (79%) of the
antigen-positive, culture-negative stool specimens. Antigen detection
was a more sensitive test for infection than antilectin antibodies,
which were detected in only 76 of 98 (78%) amebic liver abscess
patients and in 26 of 50 (52%) patients with intestinal infection. We
conclude that the TechLab E. histolytica II kit is a
sensitive means to diagnose hepatic and intestinal amebiasis prior to
the institution of metronidazole treatment.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Diagnosis of Amebic Liver Abscess and Intestinal
Infection with the TechLab Entamoeba histolytica II Antigen
Detection and Antibody Tests
*
Corresponding author. Mailing address: P.O. Box 801340, University of Virginia Health System, Charlottesville, VA 22908-1340. Phone: (804) 924-5621. Fax: (804) 924-0075. E-mail:
wap3g{at}virginia.edu.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|